City

Clinical trials near Salt Lake City, United States

Active studies with a listed research site in Salt Lake City, United States.

23active studies

15recruiting now

3countries represented

19largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 2

A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity

Adults With Overweight/Obesity and Type 2 DiabetesCondition

AT673 low dose, AT673 high doseTreatment

United States8 locations

Antag TherapeuticsSponsor

Updated 2026-09-01 · NCT07724340See eligibility →

Recruiting nowPhase 1

A Study of LY4174794 in Participants With Obesity or Overweight Who Are Otherwise Healthy

Obesity, OverweightCondition

LY4174794, LY4174794Treatment

Singapore, United States3 locations

Eli Lilly and CompanySponsor

Updated 2026-09-01 · NCT07654972See eligibility →

Recruiting nowPhase 2

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

B-cell Acute Lymphoblastic Leukemia, ObesityCondition

IDEAL2 InterventionTreatment

United States16 locations

Etan OrgelSponsor

Updated 2026-08-19 · NCT05082519See eligibility →

Recruiting nowPhase 3

Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)

Alcohol Use DisorderCondition

Semaglutide, PlaceboTreatment

United States19 locations

VA Office of Research and DevelopmentSponsor

Updated 2026-08-12 · NCT07218354See eligibility →

Recruiting nowPhase 2

Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Opioid Use Disorder, Opioid Use Disorder, ModerateCondition

Tirzepatide, PlaceboTreatment

United States9 locations

T. John Winhusen, PhDSponsor

Updated 2026-08-11 · NCT06651177See eligibility →

Recruiting nowNot applicable

Circadian Intervention to Improve Cardiometabolic Health

Cardiometabolic Syndrome, Type 2 DiabetesCondition

Circadian InterventionTreatment

United States1 locations

University of UtahSponsor

Updated 2026-08-05 · NCT05943626See eligibility →

Recruiting nowNot applicable

Effect of Sleep Extension on Ceramides in People With Overweight and Obesity

Lifestyle Factors, Overweight and ObesityCondition

Sleep Extension InterventionTreatment

United States1 locations

University of UtahSponsor

Updated 2026-08-05 · NCT06180837See eligibility →

Recruiting nowPhase 2

Sit Less, Interact and Move More (SLIMM) 2 Study

Chronic Kidney Diseases, ObesityCondition

SLIMM, Standard Resistance TrainingTreatment

United States2 locations

Srinvasan BeddhuSponsor

Updated 2026-07-27 · NCT05173714See eligibility →

Recruiting nowPhase 1

Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)

Weight ManagementCondition

GS-4571, PlaceboTreatment

United States3 locations

Gilead SciencesSponsor

Updated 2026-06-22 · NCT06562907See eligibility →

Recruiting nowNot applicable

Scaling up Building Healthy Families

Obesity, ChildCondition

Building Healthy Families ProgramTreatment

United States1 locations

University of UtahSponsor

Updated 2026-06-10 · NCT07404839See eligibility →

Recruiting nowNot applicable

Testing a Tailored Approach to Long-Term Weight Loss Success

Weight Loss, Weight RegainCondition

Adaptive weight regain preventionTreatment

United States1 locations

University of UtahSponsor

Updated 2026-05-11 · NCT07577765See eligibility →

Recruiting nowNot applicable

Mountain West Prevention Research Center Core Research Project

Childhood ObesityCondition

Text Message-based recruitment, Active outreach follow-upTreatment

United States1 locations

Paul EstabrooksSponsor

Updated 2026-03-18 · NCT07479498See eligibility →

Recruiting nowPhase 1, Phase 2

A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment

Hypothalamic Obesity, Prader-Willi SyndromeCondition

Part A: RM-718 or placebo (matched to specific RM-718 dose cohort), Part B: RM-718 or placebo (matched to specific RM-718 dose cohort)Treatment

United States7 locations

Rhythm Pharmaceuticals, Inc.Sponsor

Updated 2025-12-22 · NCT06239116See eligibility →

Recruiting nowNot applicable

PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes

Prediabetic State, Life StyleCondition

Individual intervention condition (PreventT2), Couple-based intervention condition (PreventT2 Together; couple-based adaptation of 2021 PreventT2; approved by the CDC in November 2022 as an Alternate Curriculum for use in the NDPP)Treatment

United States1 locations

University of UtahSponsor

Updated 2025-05-30 · NCT06690788See eligibility →

Recruiting nowNot applicable

The Acute T-Rex (Timing of Resistance Exercise) Study

Diabetes Mellitus, Type 2, Insulin ResistanceCondition

Resistance Exercise TimingTreatment

United States1 locations

University of UtahSponsor

Updated 2025-04-03 · NCT06366399See eligibility →

Opening soonPhase 4

Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)

Pouch, Ileal, Pouches, IleoanalCondition

Tirzepatide, LoperamideTreatment

United States5 locations

University of North Carolina, Chapel HillSponsor

Updated 2026-08-10 · NCT07756359See eligibility →

Opening soonNot applicable

Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)

ObesityCondition

Ask-Advise-Connect (AAC), Text Messaging (TM)Treatment

United States1 locations

University of UtahSponsor

Updated 2026-08-06 · NCT07582016See eligibility →

Active, not recruitingNot applicable

Long Term Outcomes of Bariatric Patients Treated With Surgery or Endoscopy

GERD, ObesityCondition

Endoscopy, SurgeryTreatment

United States6 locations

Johns Hopkins UniversitySponsor

Updated 2026-08-21 · NCT03705416See eligibility →

Active, not recruitingPhase 1

A Research Study on How NNC0638-0355, a New Medicine, Works in People Living With Overweight or Obesity

Obesity, OverweightCondition

NNC0638-0355, Placebo (NNC0638-0355)Treatment

Netherlands, United States4 locations

Novo Nordisk A/SSponsor

Updated 2026-08-17 · NCT06577766See eligibility →

Active, not recruitingNot applicable

Personalizing Financial Incentives

Obesity & OverweightCondition

personalized financial incentivesTreatment

United States1 locations

University of UtahSponsor

Updated 2026-08-13 · NCT07225426See eligibility →

Active, not recruitingPhase 2

Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression

Treatment Resistant Depression, InflammationCondition

Omega 3, PlaceboTreatment

United States3 locations

Massachusetts General HospitalSponsor

Updated 2026-07-01 · NCT05774665See eligibility →

Active, not recruitingNot applicable

Positive Psychology Intervention for Patients Post-bariatric Surgery and Their Partners

Obesity, MorbidCondition

Reimagining Us in the Context of Bariatric Surgery (ReConnect)Treatment

United States1 locations

Larissa McGarrity, Ph.D.Sponsor

Updated 2026-06-08 · NCT05958615See eligibility →

Active, not recruitingPhase 2

Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide in Participants With Obesity (RESOLVE-2)

ObesityCondition

NT-0796, PlaceboTreatment

United States9 locations

NodThera LimitedSponsor

Updated 2026-04-08 · NCT07220629See eligibility →

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.

Clinical trials near Salt Lake City, United States

Current studies

Related cities